Back to Search
JANAE SAMPSON, PHARM.D.
PHARM.D.
Pharmacist
NPI: 1427674332Individual
Specialties, Licenses & Credentials
Research & Publications (20)
Survival in women with MMR mutations and ovarian cancer: a multicentre study in Lynch syndrome kindreds.
PMID 19635727·J Med Genet·2010
4-observational
Phase 2 trial of erlotinib plus sirolimus in adults with recurrent glioblastoma.
PMID 19562254·J Neurooncol·2010
3-trial
Phase II trial of temozolomide (TMZ) plus irinotecan (CPT-11) in adults with newly diagnosed glioblastoma multiforme before radiotherapy.
PMID 19533023·J Neurooncol·2009
3-trial
Toward effective immunotherapy for the treatment of malignant brain tumors.
PMID 19560742·Neurotherapeutics·2009
6-review
Phase 1 trial of temozolomide plus irinotecan plus O6-benzylguanine in adults with recurrent malignant glioma.
PMID 19402172·Cancer·2009
3-trial
Atmospheric pressure infrared (10.6 microm) laser desorption electrospray ionization (IR-LDESI) coupled to a LTQ Fourier transform ion cyclotron resonance mass spectrometer.
PMID 19504481·Rapid Commun Mass Spectrom·2009
7-preclinical
Phase II trial of Gliadel plus O6-benzylguanine in adults with recurrent glioblastoma multiforme.
PMID 19188181·Clin Cancer Res·2009
3-trial
A constitutively active form of neurokinin 1 receptor and neurokinin 1 receptor-mediated apoptosis in glioblastomas.
PMID 19519779·J Neurochem·2009
8-other
IgE, allergy, and risk of glioma: update from the San Francisco Bay Area Adult Glioma Study in the temozolomide era.
PMID 19408307·Int J Cancer·2009
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2701 S MINNESOTA AVE
SIOUX FALLS, SD 57105 - Phone
- (605) 367-2000
Quick Facts
- NPI
- 1427674332
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile